Non-small cell lung carcinoma (NSCLC) harboring rearrangements of the anaplastic lymphoma kinase (ALK) gene and the ROS1 oncogene constitute a unique molecular subgroup of this patient population. Here, ROS1 is linked to non-small cell lung carcinoma.